Global Pituitary ACTH Hypersecretion Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Pituitary ACTH Hypersecretion Drug

• 1.1 Definition of Pituitary ACTH Hypersecretion Drug
• 1.2 Pituitary ACTH Hypersecretion Drug Segment by Type
  • 1.2.1 Global Pituitary ACTH Hypersecretion Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 AT-814
  • 1.2.3 ATR-101
  • 1.2.4 BIM-23A758
  • 1.2.5 COR-005
  • 1.2.6 CORT-125134
  • 1.2.7 ISIS-GCCRRx
  • 1.2.8 Others
• 1.3 Pituitary ACTH Hypersecretion Drug Segment by Applications
  • 1.3.1 Global Pituitary ACTH Hypersecretion Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Pituitary ACTH Hypersecretion Drug Overall Market
  • 1.4.1 Global Pituitary ACTH Hypersecretion Drug Revenue (2014-2025)
  • 1.4.2 Global Pituitary ACTH Hypersecretion Drug Production (2014-2025)
  • 1.4.3 North America Pituitary ACTH Hypersecretion Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Pituitary ACTH Hypersecretion Drug Status and Prospect (2014-2025)
  • 1.4.5 China Pituitary ACTH Hypersecretion Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Pituitary ACTH Hypersecretion Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Pituitary ACTH Hypersecretion Drug Status and Prospect (2014-2025)
  • 1.4.8 India Pituitary ACTH Hypersecretion Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Pituitary ACTH Hypersecretion Drug
• 2.3 Manufacturing Process Analysis of Pituitary ACTH Hypersecretion Drug
• 2.4 Industry Chain Structure of Pituitary ACTH Hypersecretion Drug

3 Development and Manufacturing Plants Analysis of Pituitary ACTH Hypersecretion Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Pituitary ACTH Hypersecretion Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Pituitary ACTH Hypersecretion Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Pituitary ACTH Hypersecretion Drug Production and Capacity Analysis
• 4.2 Pituitary ACTH Hypersecretion Drug Revenue Analysis
• 4.3 Pituitary ACTH Hypersecretion Drug Price Analysis
• 4.4 Market Concentration Degree

5 Pituitary ACTH Hypersecretion Drug Regional Market Analysis

• 5.1 Pituitary ACTH Hypersecretion Drug Production by Regions
  • 5.1.1 Global Pituitary ACTH Hypersecretion Drug Production by Regions
  • 5.1.2 Global Pituitary ACTH Hypersecretion Drug Revenue by Regions
• 5.2 Pituitary ACTH Hypersecretion Drug Consumption by Regions
• 5.3 North America Pituitary ACTH Hypersecretion Drug Market Analysis
  • 5.3.1 North America Pituitary ACTH Hypersecretion Drug Production
  • 5.3.2 North America Pituitary ACTH Hypersecretion Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Pituitary ACTH Hypersecretion Drug Import and Export
• 5.4 Europe Pituitary ACTH Hypersecretion Drug Market Analysis
  • 5.4.1 Europe Pituitary ACTH Hypersecretion Drug Production
  • 5.4.2 Europe Pituitary ACTH Hypersecretion Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Pituitary ACTH Hypersecretion Drug Import and Export
• 5.5 China Pituitary ACTH Hypersecretion Drug Market Analysis
  • 5.5.1 China Pituitary ACTH Hypersecretion Drug Production
  • 5.5.2 China Pituitary ACTH Hypersecretion Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Pituitary ACTH Hypersecretion Drug Import and Export
• 5.6 Japan Pituitary ACTH Hypersecretion Drug Market Analysis
  • 5.6.1 Japan Pituitary ACTH Hypersecretion Drug Production
  • 5.6.2 Japan Pituitary ACTH Hypersecretion Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Pituitary ACTH Hypersecretion Drug Import and Export
• 5.7 Southeast Asia Pituitary ACTH Hypersecretion Drug Market Analysis
  • 5.7.1 Southeast Asia Pituitary ACTH Hypersecretion Drug Production
  • 5.7.2 Southeast Asia Pituitary ACTH Hypersecretion Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Pituitary ACTH Hypersecretion Drug Import and Export
• 5.8 India Pituitary ACTH Hypersecretion Drug Market Analysis
  • 5.8.1 India Pituitary ACTH Hypersecretion Drug Production
  • 5.8.2 India Pituitary ACTH Hypersecretion Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Pituitary ACTH Hypersecretion Drug Import and Export

6 Pituitary ACTH Hypersecretion Drug Segment Market Analysis (by Type)

• 6.1 Global Pituitary ACTH Hypersecretion Drug Production by Type
• 6.2 Global Pituitary ACTH Hypersecretion Drug Revenue by Type
• 6.3 Pituitary ACTH Hypersecretion Drug Price by Type

7 Pituitary ACTH Hypersecretion Drug Segment Market Analysis (by Application)

• 7.1 Global Pituitary ACTH Hypersecretion Drug Consumption by Application
• 7.2 Global Pituitary ACTH Hypersecretion Drug Consumption Market Share by Application (2014-2019)

8 Pituitary ACTH Hypersecretion Drug Major Manufacturers Analysis

• 8.1 Alder Biopharmaceuticals Inc.
  • 8.1.1 Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.1.2 Alder Biopharmaceuticals Inc. Product Introduction, Application and Specification
  • 8.1.3 Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Corcept Therapeutics Incorporated
  • 8.2.1 Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.2.2 Corcept Therapeutics Incorporated Product Introduction, Application and Specification
  • 8.2.3 Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Cortendo AB
  • 8.3.1 Cortendo AB Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.3.2 Cortendo AB Product Introduction, Application and Specification
  • 8.3.3 Cortendo AB Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Cyclacel Pharmaceuticals, Inc.
  • 8.4.1 Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.4.2 Cyclacel Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.4.3 Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 ElexoPharm GmbH
  • 8.5.1 ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.5.2 ElexoPharm GmbH Product Introduction, Application and Specification
  • 8.5.3 ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Ipsen S.A.
  • 8.6.1 Ipsen S.A. Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.6.2 Ipsen S.A. Product Introduction, Application and Specification
  • 8.6.3 Ipsen S.A. Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Isis Pharmaceuticals, Inc.
  • 8.7.1 Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.7.2 Isis Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.7.3 Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Novartis AG
  • 8.8.1 Novartis AG Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.8.2 Novartis AG Product Introduction, Application and Specification
  • 8.8.3 Novartis AG Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Orphagen Pharmaceuticals, Inc.
  • 8.9.1 Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.9.2 Orphagen Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.9.3 Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Pfizer Inc.
  • 8.10.1 Pfizer Inc. Pituitary ACTH Hypersecretion Drug Production Sites and Area Served
  • 8.10.2 Pfizer Inc. Product Introduction, Application and Specification
  • 8.10.3 Pfizer Inc. Pituitary ACTH Hypersecretion Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Pituitary ACTH Hypersecretion Drug Market

• 9.1 Global Pituitary ACTH Hypersecretion Drug Market Trend Analysis
  • 9.1.1 Global Pituitary ACTH Hypersecretion Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Pituitary ACTH Hypersecretion Drug Regional Market Trend
  • 9.2.1 North America Pituitary ACTH Hypersecretion Drug Forecast 2019-2025
  • 9.2.2 Europe Pituitary ACTH Hypersecretion Drug Forecast 2019-2025
  • 9.2.3 China Pituitary ACTH Hypersecretion Drug Forecast 2019-2025
  • 9.2.4 Japan Pituitary ACTH Hypersecretion Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Pituitary ACTH Hypersecretion Drug Forecast 2019-2025
  • 9.2.6 India Pituitary ACTH Hypersecretion Drug Forecast 2019-2025
• 9.3 Pituitary ACTH Hypersecretion Drug Market Trend (Product Type)
• 9.4 Pituitary ACTH Hypersecretion Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Pituitary ACTH Hypersecretion Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List